Sachin Laddha PHD (Birla Institute of Technology); M-PHARM IN PHARMACEUTICAL CHEMISTRY (Rashtrasant Tukadoji Maharaj Nagpur University); B-PHARM (S K B COLLEGE OF PHARMACY KAMPTEE NAGPUR)
Birla Institute of Technology · India
Editorial leadership for Journal of Advanced Pharmaceutical Science And Technology ISSN 2328-0182
Research interests
- Medicinal Chemist
- Academician
Biography
Dr. Sachin Laddha is a medicinal chemist and academician at Birla Institute of Technology, with over 11 years of experience in research and teaching in pharmaceutical sciences. His research focuses on synthesizing new chemical entities and evaluating them for phosphodiesterase inhibitory activity, antimicrobial, anti-inflammatory, and anticonvulsant properties. He is dedicated to drug discovery and has contributed to structure-activity relationship (SAR) development in designing novel potent compounds with drug-like properties aimed for clinical candidacy. Dr. Laddha received his education from Birla Institute of Technology, Rashtrasant Tukadoji Maharaj Nagpur University, and S K B College of Pharmacy Kamptee Nagpur, and is trained in applications of various R&D equipment and related professional software.
Selected publications
- Novel fused quinazolinones: further studies on the anticonvulsant activity of 1,2,9,11-tetrasubstituted-7H-thieno[2´,3´:4,5]pyrimido[6,1-b]-quinazolin-7-one and 1,3,10,12-tetrasubstituted-8H-pyrido[2´,3´:4,5]pyrimido[6,1-b]quinazolin-8-one 2010
- cAMP-dependent phosphodiesterase inhibition and SAR studies on novel 6,8-disubstituted 2-phenyl-3-(substituted benzothiazole-2-yl)-4[3H]-quinazolinone 2009
- Efficient Niementowski synthesis of novel derivatives of 1,2,9,11-tetrasubstituted-7H-thieno[2',3':4,5]pyrimido[6,1-b]-quinazolin-7-one 2009
- A new therapeutic approach in Parkinson's disease: some novel quinazoline derivatives as dual selective phosphodiesterase 1 inhibitors and anti-inflammatory agents 2009
- Rapid Microwave-Assisted Solution Phase Synthesis of 6,8-Disubstituted 2-Phenyl-3-(substituted- benzothiazol-2-yl)-4-[3 H ]-quinazolinones as Novel Anticonvulsants 2008
- Efficient Niementowski synthesis of novel 1,3,10,12-tetra-substituted-8H-pyrido[2',3':4,5]pyrimido[6,1-b]quinazolin-8-ones 2007
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JAPST for your work?
This journal is guided by Sachin Laddha (Birla Institute of Technology) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.